LMA_MR: Muscle Relaxants on Efficacy of LMA Insertion

Sponsor
Daegu Catholic University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03487003
Collaborator
(none)
128
1
2
15.3
8.3

Study Details

Study Description

Brief Summary

The use of laryngeal mask airway (LMA) is increasing in pediatric anesthesia because it provides lesser direct mechanical stimulation of the airway due to being placed above the larynx. However, LMA insertion can be more difficult in children than in adults due to their unique characteristics of pediatric airway. Neuromuscular blocking agents, so-called, muscle relaxants have long been used to facilitate insertion of airway devices. But there are pros and cons for the efficacy of muscle relaxants in LMA insertion, and most studies were investigated in adults.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
128 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized parallel prospective non-inferiority studyRandomized parallel prospective non-inferiority study
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Comparison of the Clinical Performances of Flexible Laryngeal Mask Airway in Pediatric Patients Under General Anesthesia With or Without Muscle Relaxant: a Randomized Controlled Non-inferiority Trial
Actual Study Start Date :
Apr 20, 2018
Actual Primary Completion Date :
Jul 30, 2019
Actual Study Completion Date :
Jul 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: MR group

When the patients asleep, 0.3 mg/kg rocuronium is administered.

Drug: rocuronium
After standard anesthetic monitoring (non-invasive blood pressure monitor, pulse oximetry, 3-lead echocardiography), patients are inhaled with sevoflurane. When the patients asleep, 0.3 mg/kg rocuronium is administered. After 2 min, flexible laryngeal mask airway (fLMA) is inserted using standard method. The fLMA is inflated with air to 40 cmH2O using manometry. The oropharyngeal leak pressure (OLP) was determined by the method described by Lopez-Gil and colleagues.
Other Names:
  • Rocuronium bromide
  • Experimental: NMR group

    When the patients asleep, 0.3 mg/kg saline is administered.

    Drug: saline
    After standard anesthetic monitoring (non-invasive blood pressure monitor, pulse oximetry, 3-lead echocardiography), patients are inhaled with sevoflurane. When the patients asleep, 0.3 mg/kg saline is administered. After 2 min, flexible laryngeal mask airway (fLMA) is inserted using standard method. The fLMA is inflated with air to 40 cmH2O using manometry. The oropharyngeal leak pressure (OLP) was determined by the method described by Lopez-Gil and colleagues
    Other Names:
  • 0.9% normal saline
  • Outcome Measures

    Primary Outcome Measures

    1. Oropharyngeal leak pressure (OLP) [During 1 min after successful LMA intubation]

      It was determined by the method describe by Lopez-Gil and colleagues. Briefly, it was measured by closing the expiratory valve of the circle system at a fixed gas flow of 3l/min, recording the airway pressure at which audible leak sound was heard.

    Secondary Outcome Measures

    1. Intubation time [During 5-10 min after inhalation of sevoflurane]

      from the time of mouth opening until the time at square-wave capnography was detected

    2. Ease of intubation/mask bagging [During 5-10 min after inhalation of sevoflurane]

      After successful LMA insertion, investigator recorded subjective difficulty during whole period of LMA manipulation by Likert scale: 1, easy 2, moderate, and 3: difficult.

    3. Fiberoptic view of LMA [During 5min after successful LMA insertion]

      The fibreoptic view was assessed by fibreoptic bronchoscopy through the LMA and graded.

    4. Mean blood pressure [During 5-10 min after inhalation of sevoflurane]

      mean blood pressure (mmHg) is recorded before and after the insertion of LMA.

    5. Heart rate [During 5-10 min after inhalation of sevoflurane]

      Heart rate is (beat per minutes) recorded before and after the insertion of LMA.

    6. Watcha scale every 10 min from time to PACU admission to discharge [During 60 minutes after PACU admission]

      On arrival and every 10 min after PACU admission, patients were checked Watcha scale as following 4-point scale calm crying, but can be consoled Crying, cannot be consoled Agitated and thrashing around

    7. FLACC score on initial, 10, 20, and 30 min [During 60 minutes after PACU admission]

      Face, legs, activity, cry, and consolability (FLACC) score is checked every 10min after PACU admission

    8. Eye opening time [During 1 hour after operation]

      defined as the interval from the cessation of anesthetics to eye opening

    9. Extubation time [During 1 hour after operation]

      time from discontinuation of anesthetics to extubation

    10. Peak inspiratory pressure before and after the surgery [During 4 hour after anesthetic inhalation]

      check the peak inspiratory pressure (cmH2O) before and at the end of surgery

    11. Tidal volume ratio before and after the surgery [During 4 hour after anesthetic inhalation]

      check the expiratory tidal volume/setting tidal volume ratio before and at the end of surgery

    12. Respiratory adverse events [During 1 hour after operation]

      check the adverse events during emergence and PACU stay such as coughing, laryngospasm, bronchospasm, postoperative stridor and mild desaturation; SpO2 <95%.

    13. Postoperative complications [During 1 hour after operation]

      check the adverse events including respiratory adverse events, gastric insufflation, excessive secretion, postoperative nausea and vomiting, sore throat, and tinged blood on LMA surface.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 7 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children aged between 2 and 7 years of American Society of Anesthesiologists physical status (ASA PS) I or II who are planned to receive ophthalmic surgery under general anesthesia
    Exclusion Criteria:
    • Refusal of consent

    • Present URI or other respiratory symptoms

    • Oro or facial anomaly

    • Poor dental condition

    • who cannot open their mouth or limited mouth opening

    • when the tracheal intubation is definitely needed

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Daegu Catholic University Medical Center Daegu Korea, Republic of 42472

    Sponsors and Collaborators

    • Daegu Catholic University Medical Center

    Investigators

    • Study Chair: Eugene Kim, MD, PhD, Assistant professor

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Eugene Kim, Assistant professor, Daegu Catholic University Medical Center
    ClinicalTrials.gov Identifier:
    NCT03487003
    Other Study ID Numbers:
    • DCMC#3
    First Posted:
    Apr 3, 2018
    Last Update Posted:
    Oct 25, 2019
    Last Verified:
    Oct 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Eugene Kim, Assistant professor, Daegu Catholic University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 25, 2019